‘I am being vegetarian now': Priyanka Chopra Jonas shares her go-to meals when in India and the US; here's why they are good for you
'Dinner always starts with soup. I love having a nice, warm soup. Then, having the same that I have for lunch. It is super tasty, and healthy. Then I have various other things, I love dal, I love bhindi. I love aloo gobhi. I am being vegetarian now. Then, I always need a dahi, I love having raita and achaar is very important. Salad's very important,' she told the host.
'Now when I'm in the US, I am usually not a sandwich person. I don't like sandwiches, but I always like roast fish with veggies. I love a good, fresh salad,' she added.
Many like to begin their meals with a bowl of scrumptious and filling soup. But, turns out, apart from being an appetiser, beginning a meal with soup also has several health benefits!
Delhi-based nutritionist Pooja Bohra shared some benefits to starting your meals with a warm vegetable soup:
*It is a high source of fluids.
*Soups are healthy and nutritious.
*Soup preserves its nutritional value.
*They are full of healthy fibres.
*Soups are rich in taste.
*It is a powerhouse of antioxidants.
*Soups fill up the volume in your stomach.
*It leaves less room for more calorie-dense food item
Kanikka Malhotra, consultant dietician and certified diabetes educator, tells indianexpress.com, 'Regular consumption of curd after lunch can significantly alter gut microbiota composition due to its probiotic content, primarily Lactobacillus and Bifidobacterium strains. These live cultures enhance beneficial bacterial populations, improving microbial diversity and suppressing harmful bacteria.
According to her, the lactic acid bacteria in curd strengthens gut barrier function, reduces inflammation, and promotes short-chain fatty acid production, which supports colon health. Curd's probiotics also improve nutrient absorption, reduce bloating, and may lower the risk of inflammatory bowel conditions by balancing gut flora.
However, pairing curd with spicy dishes may not be suitable for all. The contrast in temperature between cold curd and hot spices could lead to digestive discomfort, particularly in individuals with sensitive stomachs. 'There is no evidence suggesting that the combination is harmful. However, some individuals with sensitive stomachs might experience discomfort due to the contrasting temperatures,' she added.
Sushma PS, chief dietitian, Jindal Naturecure Institute said that salads are alkaline foods that serve as a preventive measure against acid accumulation within the body, supporting gentle detoxification processes. 'The consumption of a salad promotes gastrointestinal health by incorporating ingredients characterised by low acidity levels and rich fibre, vitamin, and mineral content, which are essential for digestive well-being,' said Sushma.
DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
2 minutes ago
- Mint
Jashvik Capital acquires stake in pharma software provider Marg ERP for over ₹400 crore
Private equity firm Jashvik Capital said on Wednesday that it has acquired a stake in pharma software provider Marg ERP for over ₹400 crore, marking the firm's fourth investment from its maiden fund, which has a target corpus of $350 million. The firm is betting on the growth of organised healthcare software as a service (SaaS) in the Indian market, where Marg ERP is currently a market leader. The healthcare software services market in India has been largely unorganised, but with tailwinds like an increasing focus on digitisation, tightening regulatory processes, and a rise in consumer trends, this space is expected to grow, founder and managing partner Naresh Patwari told Mint. 'Healthcare SaaS has been a very large opportunity globally. We think we are at the start of that super cycle in India," said Patwari. 'Our view is that while India is in the early stages of this transformation, our investment in Marg ERP is the first step in building a platform that can ride this super cycle." Jashvik Capital, a mid-market PE firm, has in the past made investments in Bharuch-based Jabsons Foods, Bengaluru-based Futura Surgicare and Hyderabad-based eye care chain Smart Vision Eye Specialities Pvt. Ltd. It is also in the process of closing an investment in pest control and home care products maker Midas Hygiene, which it had announced in February. Marg ERP, founded in 2000, is one of the country's largest ERP (enterprise resource planning) and accounting software providers for pharmaceutical retailers and wholesalers. The firm currently has over 500,000 subscribers and is present in India and 32 other countries. It works largely with players across the pharmaceutical distribution chain, including wholesalers, distributors and pharmacies. It has a market share of over 50% in some segments in the distribution chain, said Patwari. 'Marg is a highly profitable, fast-growing company. Growth has been 25% over the long term and close to 40% more recently. It is a clear market leader and it can compound for the next 10-15 years. We are perhaps at the early stages of a long-term trend," he said. The firm plans to scale up Marg's operations through a mix of organic and inorganic strategies, as well as invest further in R&D, said Patwari. '...the goal is to expand, go deeper in India and to go wider internationally." API Holdings, India's largest digital healthcare platform and parent company of brands like PharmEasy, had acquired a 49% stake in Marg ERP in 2022, which the company's founders bought back in February this year.
Time of India
2 minutes ago
- Time of India
W Health Ventures targets $70 million Fund II to build healthcare startups
Academy Empower your mind, elevate your skills US venture capital firm W Health Ventures is looking to raise $70 million, or about Rs 610 crore, for its second India-focused fund to back healthcare startups in the fund will support the development of eight to ten seed and early-stage healthcare companies over the next four years, in partnership with 2070 Health, a healthcare venture studio, W Health Ventures managing partner Pankaj Jethwani told ET.W Health plans to invest Rs 26-40 crore ($3-5 million) per company, with additional capital reserved for follow-ons, he company-creation model offers infrastructure, capital, and operational know-how from the incubation stage.'The company creation model is particularly suited for healthcare due to the sector's inherent challenges, such as its slow pace of change, heavy regulation, and complexity,' Jethwani said. 'This approach helps founders overcome bottlenecks by leveraging the fund's data, relationships, playbooks, and teams to build companies from zero to one.'Fund II will focus on two core themes: single-specialty care delivery platforms and AI-enabled business-to-business (B2B) healthcare first theme will back startups offering high-quality, efficient care in specific medical second will target B2B companies catering to the growing demand from US-based healthcare firms for technology solutions powered by India's clinical and engineering talent pool. These startups are expected to use automation and artificial intelligence (AI) to drive operational efficiency for international clients.'AI is no longer optional when building a company, including in healthcare, though it doesn't always have to be the primary product,' Jethwani said. 'The technology is crucial for embedding convenience and high-quality care at every step.'W Health has already begun deploying capital from the new first investment from Fund II was in EverHope Oncology, which raised $10 million in a seed round. W Health led the round in partnership with Narayana Health and 2070 Health, as reported by ET.W Health's first fund of around $50 million backed startups such as AI-enabled mental health platform Wysa; Elevate Now, a medical weight-loss programme; and Kins, a US-based virtual and home-based physical therapy platform. Its other investments included startups in paediatric care and pain in 2019, W Health has backed companies across various healthcare domains, including digital health, chronic disease management, and mental has seen a rise in sector-specific venture capital funds that focus on defined themes such as healthtech, deeptech, cleantech, and consumer tech. Examples include Java Capital, which backs deeptech and climate tech startups; Avaana Capital, focused on consumer, food and agritech; and Delhi-based Sauce VC, which invests in consumer brands.
Time of India
25 minutes ago
- Time of India
W Health Ventures targets $100 million second fund
W Health Ventures team (L-R) Dr Pankaj Jethwani (executive VP & managing partner), Gaurav Porwal (partner & chief operating officer) and Bhavesh Hemani (chief financial officer) BENGALURU: W Health Ventures, founded by serial technology entrepreneur, investor and philanthropist Sunil Wadhwani, has launched its second fund targeting $70 million (RS 600 crore) with a hard cap of $100 million (Rs 850 crore). The healthcare-focused venture capital firm, which operates in Boston and India, expects to announce the fund's first close later this quarter. Fund II will double down on W Health's 'company creation' approach, which is building and scaling healthcare businesses from the ground up while backing existing platforms. The model, which the firm says helped its first fund's portfolio reach over 25 million patients globally, will now be expanded with plans to build eight to ten companies over the next four years. 'We're in an evergreen sector that will continue to grow at a reasonable pace for the next 20 years,' Dr. Pankaj Jethwani, managing partner at W Health Ventures, told TOI. 'Healthcare innovation in India remains 10-15 years behind global benchmarks. That gap is a generational opportunity.' The firm has already warehoused two investments for Fund II. These include Everhope Oncology, a $10 million joint venture with Narayana Health aimed at reimagining cancer care in India by introducing advanced diagnostics, breakthrough therapies and decentralised treatment centres, and a US-based managed services platform for psychiatric care that operates in stealth. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Europe's 30 Most Beautiful Hidden Coastal Towns – Ranked by Travel Lovers Learn More Undo W Health will also strengthen its leadership with four new senior operating partners who will provide hands-on expertise in areas such as offline healthcare operations, AI-enabled services and US go-to-market. Jethwani said the firm's strategy is built on two themes: single-speciality care delivery platforms in India and cross-border, AI-enabled B2B healthcare services. 'Most of healthcare spend in India still happens offline,' he told TOI. 'We are focused on building companies that meet patients where they are while also leveraging India's clinical and engineering talent to power healthcare services for global markets. ' W Health launched its first fund in 2021, deploying about $43 million across 12 companies, including Mylo, BeatO, Wysa, Reveal HealthTech and Nivaan Care. Jethwani added that healthcare has been among the strongest-performing investment categories in India. 'We're not a healthtech fund, we're a healthcare fund. We are here to build companies that can truly change the standard of care for millions of patients.' Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025
